Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2020 2020-02-05
Next Day Disclosure Return 2020-01-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019 2020-01-06
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD 2020-01-05
INSIDE INFORMATION ANNOUNCEMENT – COLLABORATIVE PARTNERSHIP AGREEMENT WITH TRACON AND 3DMED 2019-12-20
VOLUNTARY ANNOUNCEMENT - COMPLETION OF CONSTRUCTION OF THE PHASE I MANUFACTURING FACILITIES 2019-12-18
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE II CLINICAL TRIAL OF KN019 FOR RHEUMATOID ARTHRITIS TREATMENT IN CHINA 2019-12-16
Terms of Reference of the Strategy Committee 2019-12-11
Terms of Reference of the Remuneration Committee 2019-12-11
Terms of Reference of the Audit Committee 2019-12-11